Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. The BSA-based method of dose calculation was adopted without adequate investigation of its ...

Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study A total of 1,206 adult ...

Enhertu is a targeted medication used to treat specific HER2-positive or HER2-low cancers. Dosage is determined by body weight and the specific condition being treated. The following table shows ...